These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 3909339

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
    LeFrock JL, Smith BR, Chandrasekar P, Rolston KV, Molavi A, Kannangara W.
    Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
    [Abstract] [Full Text] [Related]

  • 3. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE, Neu HC.
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [Abstract] [Full Text] [Related]

  • 4. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
    McKellar PP.
    Rev Infect Dis; 1985 Feb; 7 Suppl 4():S803-9. PubMed ID: 3909340
    [Abstract] [Full Text] [Related]

  • 5. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
    Henry SA, Bendush CB.
    Am J Med; 1985 Feb 08; 78(2A):57-64. PubMed ID: 3881950
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
    Clergeot A, Steru D, Rosset MA, Carbon C.
    Rev Infect Dis; 1991 Feb 08; 13 Suppl 7():S648-51. PubMed ID: 2068476
    [Abstract] [Full Text] [Related]

  • 7. Clinical experience with aztreonam in Europe: a summary of studies in Belgium, England, Finland, Ireland, the Netherlands, Norway, Portugal, and Sweden.
    Norrby SR.
    Rev Infect Dis; 1985 Feb 08; 7 Suppl 4():S836-9. PubMed ID: 2934788
    [Abstract] [Full Text] [Related]

  • 8. Current state of infectious diseases--potential areas of directed therapy with aztreonam.
    Neu HC.
    Am J Med; 1985 Feb 08; 78(2A):77-80. PubMed ID: 4038580
    [Abstract] [Full Text] [Related]

  • 9. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy.
    Cook JL.
    Am J Med; 1990 Mar 23; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
    Trujillo H, Harry N, Arango A, Benítez G, Restrepo F, Mejía GI, Castrillón AL.
    Chemotherapy; 1989 Mar 23; 35 Suppl 1():25-30. PubMed ID: 2731447
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical experience with aztreonam in four Mediterranean countries.
    Daikos GK.
    Rev Infect Dis; 1985 Mar 23; 7 Suppl 4():S831-5. PubMed ID: 2934787
    [Abstract] [Full Text] [Related]

  • 15. Treatment of serious gram-negative infections with aztreonam.
    Greenberg RN, Reilly PM, Luppen KL, McMillian R, Bollinger M, Wolk SM, Darji TB, Noorani AA.
    J Infect Dis; 1984 Nov 23; 150(5):623-30. PubMed ID: 6541672
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of aztreonam in the treatment of serious gram-negative infections in a university hospital in Saudi Arabia.
    Fayed DF, Dahmash NS, Saddique AA, Shibl AM.
    J Chemother; 1992 Jun 23; 4(3):167-70. PubMed ID: 1517810
    [Abstract] [Full Text] [Related]

  • 17. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
    Rabinad E, Bosch-Perez A.
    Chemotherapy; 1989 Jun 23; 35 Suppl 1():1-7. PubMed ID: 2659288
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.
    Schentag JJ, Vari AJ, Winslade NE, Swanson DJ, Smith IL, Simons GW, Vigano A.
    Am J Med; 1985 Feb 08; 78(2A):34-41. PubMed ID: 3881947
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of aztreonam in the treatment of severe bacterial infections.
    Romero-Vivas J, Rodríguez-Créixems M, Bouza E, Hellín T, Guerrero A, Martínez-Beltrán J, García de la Torre M.
    Antimicrob Agents Chemother; 1985 Aug 08; 28(2):222-6. PubMed ID: 3834832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.